These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7728650)

  • 21. Controversies in the medical treatment of ischaemic heart disease. Nitrates? Beta-blockers? Calcium blockers?
    Eur Heart J; 1985 Jan; 6 Suppl A():1-52. PubMed ID: 2859990
    [No Abstract]   [Full Text] [Related]  

  • 22. ["Historic" calcium antagonists and ischemic cardiopathy: critical review of the literature].
    De Servi S; Mariani G; Barberis P
    G Ital Cardiol; 1992 May; 22(5):585-94. PubMed ID: 1426797
    [No Abstract]   [Full Text] [Related]  

  • 23. [Direction of pharmacotherapeutic changes used in cardiovascular diseases assessed by examination of two population samples from Warsaw].
    Kuźmińska A; Pìotrowski W; Rywik S; Broda G; Polakowska M
    Pol Arch Med Wewn; 1994 Dec; 92(6):489-98. PubMed ID: 7716052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac metabolism in ischemic heart disease.
    Opie LH
    Arch Mal Coeur Vaiss; 1999 Dec; 92(12):1755-60. PubMed ID: 10665328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical therapy for silent myocardial ischemia.
    Pepine CJ; Hill JA
    Circulation; 1987 Mar; 75(3 Pt 2):II43-4. PubMed ID: 2880679
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of silent ischemia].
    Mlczoch J
    Acta Med Austriaca; 1992; 19(3):70-3. PubMed ID: 1357905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Views on the use of calcium channel blockers in the treatment of heart ischemia and hypertension].
    Halawa B
    Pol Merkur Lekarski; 1998 Sep; 5(27):107-10. PubMed ID: 10101470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revascularization procedures in the treatment of single-vessel coronary disease.
    Parisi AF; Burtt DM
    Coron Artery Dis; 1993 Dec; 4(12):1053-60. PubMed ID: 7909263
    [No Abstract]   [Full Text] [Related]  

  • 29. [Heart rate control: f-channel blockers].
    Kryzhanovskiĭ SA; Vititnova MB
    Fiziol Cheloveka; 2009; 35(2):112-23. PubMed ID: 19402561
    [No Abstract]   [Full Text] [Related]  

  • 30. New aspects of the treatment of ischemic heath disease with calcium antagonists. Proceedings of the International Nisoldipine Symposium. Düsseldorf, Germany, March 27-29, 1992.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S1-81. PubMed ID: 1282607
    [No Abstract]   [Full Text] [Related]  

  • 31. [An evaluation of the efficacy of treating IHD patients with calcium antagonists].
    Mordovin VF; Triss SV; Fedorova NA; Chernov VI; Krylov A; Pavliukova EN; Karpov RS
    Ter Arkh; 1995; 67(6):5-8. PubMed ID: 7667781
    [No Abstract]   [Full Text] [Related]  

  • 32. Daily life cardiac ischaemia. Should it be treated?
    Bertolet BD; Pepine CJ
    Drugs; 1995 Feb; 49(2):176-95. PubMed ID: 7729326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antianginal Agents for the Management of Stable Ischemic Heart Disease: A Review.
    Mody P; Sidhu MS; Brilakis ES; Sacco JD; Banerjee S; Boden WE
    Cardiol Rev; 2016; 24(4):177-89. PubMed ID: 26274534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The characteristics of the Holter monitoring data on patients with a vasospastic reaction during the performance of transesophageal electrocardiostimulation].
    Tashchuk VK; Malinovskaia IE
    Lik Sprava; 1992 Aug; (8):15-8. PubMed ID: 1475917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical roles of calcium channel blockers in ischemic heart diseases.
    Sueta D; Tabata N; Hokimoto S
    Hypertens Res; 2017 May; 40(5):423-428. PubMed ID: 28123178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium channel blockers for ischemia after cardiopulmonary bypass.
    Jain U
    J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):922-3. PubMed ID: 9412900
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evolution of the market of calcium dihydropyridinic antagonists and their use in the treatment of chronic forms of ischemic heart disease].
    Strashnyĭ VV; Lysenko AF
    Lik Sprava; 2002; (5-6):16-20. PubMed ID: 12442510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The experimental study of myocardial protection for warm myocardial ischemia in an isolated rat heart: the effect of a calcium antagonist].
    Fukuhiro Y
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Feb; 44(2):130-7. PubMed ID: 8717259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A method for optimizing the finoptin treatment of patients with ischemic heart disease].
    Synchuk AN; Chursina TIa; Rozgon GI; Troian NF; Kiriliuk NA; Glibka AZ
    Lik Sprava; 1995; (3-4):140-2. PubMed ID: 8819947
    [No Abstract]   [Full Text] [Related]  

  • 40. The patient with chronic ischemic heart disease. Role of ranolazine in the management of stable angina.
    Di Monaco A; Sestito A
    Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1611-36. PubMed ID: 23161033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.